Literature DB >> 20875740

Identification of optimum computational protocols for modeling the aryl hydrocarbon receptor (AHR) and its interaction with ligands.

Ashutosh S Jogalekar1, Stephan Reiling, Roy J Vaz.   

Abstract

The aryl hydrocarbon receptor (AHR) is one of the principal xenobiotic receptors in living organisms and is responsible for interacting with several drugs and environmental toxins, most notably tetrachlorodibenzodioxin (TCDD). Binding of diverse agonists to AHR initiates an extensive set of downstream gene expression responses and thus identifies AHR among a key set of proteins responsible for mediating interactions between living organisms and foreign molecules. While extensive biochemical investigations on the interaction of AHR with ligands have been carried out, studies comparing the abilities of specific computational algorithms in explaining the potency of known AHR ligands are lacking. In this study we use molecular dynamics simulations to identify a physically realistic conformation of the AHR that is relevant to ligand binding. We then use two sets of existing data on known AHR ligands to evaluate the performance of several docking and scoring protocols in rationalizing the potencies of these ligands. The results identify an optimum set of protocols that could prove useful in future AHR ligand discovery and design as a target or anti-target. Exploration of the details of these protocols sheds light on factors operating in modeling AHR ligand binding.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875740     DOI: 10.1016/j.bmcl.2010.09.019

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  New aryl hydrocarbon receptor homology model targeted to improve docking reliability.

Authors:  Ilaria Motto; Annalisa Bordogna; Anatoly A Soshilov; Michael S Denison; Laura Bonati
Journal:  J Chem Inf Model       Date:  2011-11-02       Impact factor: 4.956

2.  Identification of the Ah-receptor structural determinants for ligand preferences.

Authors:  Yongna Xing; Manabu Nukaya; Kenneth A Satyshur; Li Jiang; Vitali Stanevich; Elif Nihal Korkmaz; Lisa Burdette; Gregory D Kennedy; Qiang Cui; Christopher A Bradfield
Journal:  Toxicol Sci       Date:  2012-06-02       Impact factor: 4.849

3.  Comparative analysis of homology models of the AH receptor ligand binding domain: verification of structure-function predictions by site-directed mutagenesis of a nonfunctional receptor.

Authors:  Domenico Fraccalvieri; Anatoly A Soshilov; Sibel I Karchner; Diana G Franks; Alessandro Pandini; Laura Bonati; Mark E Hahn; Michael S Denison
Journal:  Biochemistry       Date:  2013-01-14       Impact factor: 3.162

4.  Insight into the dynamic interaction between different flavonoids and bovine serum albumin using molecular dynamics simulations and free energy calculations.

Authors:  Xiaodi Niu; Xiaohan Gao; Hongsu Wang; Xin Wang; Song Wang
Journal:  J Mol Model       Date:  2012-11-01       Impact factor: 1.810

5.  Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation.

Authors:  Shanshan Guan; Tianao Wang; Ziyu Kuai; Mengdan Qian; Xiaopian Tian; Xiuqi Zhang; Yongjiao Yu; Song Wang; Hao Zhang; Hao Li; Wei Kong; Yaming Shan
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

6.  Insights into structure and activity of natural compound inhibitors of pneumolysin.

Authors:  Hongen Li; Xiaoran Zhao; Xuming Deng; Jianfeng Wang; Meng Song; Xiaodi Niu; Liping Peng
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

7.  Luteolin Binds Streptolysin O Toxin and Inhibits Its Hemolytic Effects and Cytotoxicity.

Authors:  Tingting Guo; Peng Liu; Zeyu Wang; Yuling Zheng; Wenhua Huang; Decong Kong; Lizhong Ding; Qingyu Lv; Zhongtian Wang; Hua Jiang; Yongqiang Jiang; Liping Sun
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.